Dr. Agarwal’s Health Care Monitoring Report for Quarter Ended December 31, 2025
Dr. Agarwal’s Health Care Limited’s monitoring agency report for the quarter ending December 31, 2025, confirms that the…
Multi Commodity Exchange Q3 FY26 Revenue Surges 121%
Multi Commodity Exchange (MCX) reported strong Q3 FY26 results, with revenue from operations increasing by 121% year-over-year to INR 666…
Indian Railway Finance Corporation Diversifies into Port Infrastructure with Tuticorin MoU
Indian Railway Finance Corporation (IRFC) has signed a tripartite MoU with V.O. Chidambaranar Port Authority (VOCPA) and Sagarmala Finance…
South Indian Bank Appoints Jose Joseph Kattoor as Non-Executive Chairman
South Indian Bank has appointed Jose Joseph Kattoor as the Non-Executive Part Time Chairman (Independent Director), effective March 23, 2026.…
Aarti Drugs Q3 FY26 Revenue Up 8% YoY, Formulation Segment Soars
Aarti Drugs reports an 8% YoY increase in revenue to ₹602.9 crore for Q3 FY26. The Formulation segment shines with a 59% YoY surge. EBITDA…
Dr. Agarwal’s Health Care Grants Employee Stock Options
Dr. Agarwal’s Health Care Limited has granted 4,44,500 stock options to its eligible employees and those of its subsidiaries under the…
Signature Global Reports Strong Sales and Expansion in 9M’FY26
Signature Global announced strong performance in 9M’FY26, selling over 1,700 units with an average ticket size of INR 38.2 Mn. Sales…
Aarti Drugs Q3 FY26 Financial Results and Business Highlights
Aarti Drugs reports revenue of ₹602.9 crore for Q3 FY26, an 8% year-over-year increase. EBITDA stood at ₹56.3 crore with a margin of 9.3%. The…
Dr. Agarwal’s Strong Q3, Total Income Up 20.8% to ₹1,548 Crores
Dr. Agarwal’s Health Care Limited announced strong unaudited consolidated financial results. Total income for 9M’FY2026 soared by…
Kansai Nerolac Q3 FY26 Results Show Revenue Growth
Kansai Nerolac Paints Ltd (KNPL) announced its Q3 FY2026 results, reporting a net revenue of ₹1907.35 Crores, a 3.5% increase year-over-year.…